Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$11.8 - $13.78 $454,359 - $530,598
-38,505 Reduced 29.14%
93,632 $1.24 Million
Q3 2022

Nov 10, 2022

SELL
$11.61 - $15.22 $1.24 Million - $1.62 Million
-106,591 Reduced 44.65%
132,137 $1.53 Million
Q2 2022

Aug 11, 2022

BUY
$14.32 - $19.88 $1.08 Million - $1.5 Million
75,272 Added 46.05%
238,728 $3.59 Million
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $847,465 - $1.12 Million
55,066 Added 50.8%
163,456 $3.14 Million
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $187,690 - $220,839
11,797 Added 12.21%
108,390 $1.87 Million
Q3 2021

Nov 12, 2021

BUY
$13.06 - $17.24 $1.26 Million - $1.67 Million
96,593 New
96,593 $1.61 Million
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $1.46 Million - $1.95 Million
-156,181 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$10.33 - $14.49 $468,124 - $656,643
-45,317 Reduced 22.49%
156,181 $1.6 Million
Q2 2020

Aug 13, 2020

SELL
$11.49 - $15.26 $4.79 Million - $6.36 Million
-416,854 Reduced 67.41%
201,498 $2.82 Million
Q1 2020

May 15, 2020

BUY
$8.11 - $15.23 $184,599 - $346,665
22,762 Added 3.82%
618,352 $7.62 Million
Q4 2019

Feb 11, 2020

BUY
$10.28 - $14.38 $279,739 - $391,308
27,212 Added 4.79%
595,590 $8.43 Million
Q3 2019

Nov 12, 2019

SELL
$10.05 - $14.55 $1.74 Million - $2.52 Million
-173,053 Reduced 23.34%
568,378 $5.85 Million
Q2 2019

Aug 08, 2019

SELL
$13.1 - $14.95 $462,927 - $528,303
-35,338 Reduced 4.55%
741,431 $10.8 Million
Q1 2019

May 14, 2019

BUY
$13.69 - $20.06 $4.22 Million - $6.18 Million
308,000 Added 65.7%
776,769 $10.9 Million
Q4 2018

Feb 14, 2019

BUY
$13.96 - $18.26 $1.1 Million - $1.44 Million
78,987 Added 20.26%
468,769 $8.18 Million
Q3 2018

Nov 13, 2018

BUY
$13.63 - $15.7 $4.32 Million - $4.98 Million
317,260 Added 437.47%
389,782 $5.94 Million
Q2 2018

Aug 13, 2018

SELL
$13.44 - $17.59 $1.53 Million - $2.01 Million
-114,051 Reduced 61.13%
72,522 $998,000
Q1 2018

May 11, 2018

BUY
$13.8 - $16.99 $1.69 Million - $2.08 Million
122,276 Added 190.17%
186,573 $3.11 Million
Q4 2017

Feb 09, 2018

BUY
$11.73 - $14.75 $140,314 - $176,439
11,962 Added 22.86%
64,297 $912,000
Q3 2017

Nov 09, 2017

BUY
$12.06 - $14.12 $631,160 - $738,970
52,335
52,335 $731,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.